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a  b  s  t  r  a  c  t
Permethrin  is  a synthetic  Type  I pyrethroidal  neurotoxic  pesticide  that  has  been  responsi-
ble for  accidental  animal  deaths.  Despite  its widespread  use,  there  are  no  published  case
reports on pediatric  intensive  care  unit  admissions  due  to  permethrin  exposure.  We  report





tertiary care  pediatric  intensive  care  unit  (PICU).  While  there  is no standard  clinical  diagnos-
tic test  for  permethrin,  accurate  diagnosis  was  obtained  by  rapidly  analyzing  the offending
agent.  In the  absence  of a known  antidote  for permethrin,  supportive  management  was
initiated  and  resulted  in a favorable  outcome  for all three  siblings.
© 2014  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is  an  open  access  article  under
the CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Background
Permethrin is a synthetic Type I pyrethroidal pesticide
that is commonly used worldwide on crops. It is highly toxic
to  animals, particularly ﬁsh and cats. It is primarily a neu-
rotoxin  and its main mechanism of action is axonal sodium
channel depolarization causing repetitive nerve impulses
[1].  At relatively high concentrations, pyrethroids can act
on  gamma-aminobutyric acid (GABA)-gated chloride chan-
nels,  which may  be responsible for the seizures seen with
severe  Type II poisoning [2]. Despite its widespread use,
there  are few recorded cases of human toxicity and fewer
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(http://creativecommons.org/licenses/by-nc-nd/3.0/).reports of pediatric intensive care unit (PICU) admissions
with good outcomes.
2.  Patient presentations
We  describe the following case summaries of three
siblings who presented simultaneously to the PICU with
varied  clinical symptoms resulting from what was ini-
tially  suspected to be organophosphate poisoning. All three
patients  were originally exposed to an unknown sub-
stance used to bathe a puppy. They initially presented to
an  outside medical facility following the exposure, which
included both topical contact and ingestion. It is unknown
how much of the substance was found at the location where
exposure occurred. After sampling by the local Fire Depart-
ment  of the substance found on a trampoline, emergent
analysis of the unknown substance identiﬁed it as per-
methrin. Subsequently, the patients were diagnosed with
acute  permethrin poisoning.
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Patient #1 is a ﬁve-year-old previously healthy female
ho, along with her siblings, had bathed a puppy, poured
he  unknown chemical on a trampoline, then played with it
nd  possibly ingested some of it. Eight hours following sus-
ected  ingestion, she presented to an outside Emergency
epartment (ED) with symptoms of increased lacrima-
ion, salivation, bronchorrhea, vomiting, stomach cramps,
nd  signiﬁcant respiratory depression and altered mental
tatus.  She was intubated, volume-resuscitated and admin-
stered  two doses of 1 mg  atropine, then transferred to
he  PICU at our facility. Upon admission, she manifested
ymptoms of excessive secretions and pinpoint pupils.
ence, she was given two further doses of 1 mg  atropine
ith no therapeutic response. The patient continued to
e  comatose with no response to anticholinergic manage-
ent; hence, the chemical found at the site of exposure was
mergently analyzed and determined to be permethrin and
ot  organophosphate, as initially suspected.
The existing literature was reviewed, poison control was
ontacted again and further treatment was discussed as
eing  mainly supportive. Continuous bedside electroen-
ephalogram (EEG) monitoring was performed because
f  the potential for permethrin to cause subclinical sta-
us  epilepticus. Subsequently, benzodiazepine therapy was
nitiated.  The patient remained comatose and on mechan-
cal  ventilation with poor deep tendon reﬂexes, muscle
eakness, pinpoint pupils, increased secretions and diar-
hea,  and elevated body temperature for one week. Head
omputed tomography (CT) and magnetic resonance imag-
ng  (MRI) scans were reported as negative. She was started
n  gabapentin for possible paresthesia, a known associa-
ion  with permethrin toxicity. After eight days, the patient
as  extubated after demonstrating improved responsive-
ess, normal pupils, and decreased secretions.
Patient #2 is a six-year-old female with similar exposure
istory. As this patient was related to Patient #1, diag-
osis was made again based on the chief complaint and
istory  of present illness, suspected ingestion of perme-
hrin. Her initial presentation was not as severe as her
ister’s, and did not require intubation at the outside ED.
he  received one dose of atropine and was transferred
o the PICU for observation. After a few hours, her men-
al  status deteriorated and she was intubated to protect
er  airway from excessive secretions. Unlike Patient #1,
he  also demonstrated signs of aspiration pneumonitis and
bnormal  motor movements. Her course was otherwise
imilar with high fever, pinpoint pupils, altered mental sta-
us,  muscle weakness, profuse secretions and diarrhea. Her
ovements were random, non-purposeful, and very difﬁ-
ult  to control despite sedation. She responded to a low,
efasciculating dose of pancuronium with an improvement
f  her movements. However, she had the longest ICU course
nd  remained mechanically ventilated for 12 days.
Patient #3 is an eight-year-old female who ingested the
ame  chemical as the two siblings previously presented.
gain, the chemical ingested was sampled by the local Fire
epartment and subsequently tested and identiﬁed as per-
ethrin.  However, this patient possibly did not have the
ame  level of exposure as her siblings, as she had tried
o  wash the permethrin off the puppy after the other sib-
ings  had doused it. It is suspected that this patient ingestedts 1 (2014) 1026–1028 1027
less  than her siblings, as she presented with symptoms of
vomiting  and stomach cramps. Her total length of stay in
the  hospital was  two  days, with one day in the ICU. She
never  demonstrated central nervous system effects, pupil-
lary  changes or increased secretions. Her laboratory data
were  within normal limits. The puppy, unfortunately, was
reported  to have died from this exposure.
3. Discussion
This is the ﬁrst report of a set of children simul-
taneously presenting with permethrin toxicity with
differing clinical spectra with successful outcomes. Lack of
standard  management response to previously suspected
organophosphate poisoning prompted a rapid analysis of
the  offending toxin, conﬁrming the toxin as permethrin
in these three cases. Unfortunately, bodily ﬂuid analysis
was not performed. However, the substance was  chem-
ically  analyzed and a diagnosis of permethrin poisoning
was made. It would have been useful if red blood cell
acetylcholinesterase (RBC-AChE) could have been used as
a  conﬁrmatory test for toxicity resulting from exposure
to organophosphorus compounds, speciﬁcally in ICU man-
agement  of these patients [3]; however, that test was
unavailable in our geographical area.
Review of existing literature reveals a paucity of cases
of  human toxicity with permethrin. It appears to be par-
ticularly rare in children and the presentations may  be
variable; however, in vivo, permethrin is almost ﬁve times
more  acutely toxic to eight-day-old rats than to adult rats.
Based  on in vivo experiments, it is possible that children
may  be more sensitive to permethrin than adults [4]. A
study  performed at an Ohio daycare center to analyze path-
ways  of exposure to permethrin in children concluded that
children  are exposed to low levels from several sources
and through several routes; however, the exposure did not
result  in symptoms of apparent toxicity [5]. Based on these
studies  in combination with our patient presentations,
it is suspected that lower levels of exposure to perme-
thrin can likely cause either none or minor side effects,
whereas exposure to higher doses of permethrin can
lead  to worsened symptoms. In addition, the detection of
urinary  metabolites, cis- and trans-3-(2,2-dichlorovinyl)-
2,2-dimethylcyclopropane-1-carboxylic acids, have been
previously used in suspected permethrin toxicity cases,
however, they were not tested for in these patients, as the
tests  are not available in our geographical area [6].
A  review of 48 cases of acute ingestion-related
poisoning with pyrethroids in Taiwan revealed that
gastrointestinal tract signs and symptoms were most com-
mon,  found in 73% of cases [7]. Pulmonary abnormalities
were found in 29% of cases, including aspiration pneumoni-
tis  and pulmonary edema [7], as evident in our second case.
Central  nervous system involvement, as demonstrated in
the  ﬁrst case described here, was found in 33% cases and
included confusion, coma and seizures [7].
The biodegradation of synthetic pyrethroidal com-
pounds has been extensively studied [8–10]. Permethrin
is a synthetic Type I pyrethroid with a high selectivity for
insects.  It has four isomers with 1R cis-permethrin being
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insects by strongly exciting their nervous systems. They
make  the nervous system hypersensitive to stimuli from
sensory organs. Permethrin-exposed nerves send a train of
impulses,  instead of a single impulse, in response to a stim-
ulus.  It does this by interacting with the voltage-dependent
sodium channels and produces a prolongation of inward
sodium current, and hence the channels remain open much
longer,  causing repetitive nerve impulses [11]. Permethrin
has  been shown in vitro and in vivo to increase acetylcholine
and acetylcholinesterase levels [12,13]. Monoamine oxi-
dase  and ATPase enzymes are inhibited by permethrin
[1,2,10]. It has been reported to inhibit the GABA recep-
tor,  producing excitability and convulsions [2,11]. At high
doses,  neurotoxic symptoms can include tremors, incoor-
dination, hyperactivity, paralysis, and hyperthermia [14].
Some  other effects are irritation to the eyes and skin. It
is  classiﬁed as a carcinogen and is a mutagen of human
cell cultures [14]. The patients in this report were initially
treated with atropine, which had no effect. An expla-
nation for treatment failure could be that the atropine
dose administered was not potent enough to overcome
the permethrin toxin load. However, there is no liter-
ature supporting treatment of permethrin toxicity with
atropine.
4.  Conclusion
Permethrin is a very common and highly effective pes-
ticide widely used around the world; however, reports of
toxicity  in the pediatric literature are infrequent. The most
common  symptoms appear to be nausea and vomiting.
Neurotoxicity appears to be most clinically signiﬁcant. Per-
methrin  toxicity may  mimic  organophosphate poisoning
because of its cholinergic actions. Treatment for perme-
thrin toxicity is mainly supportive, including protection of
the  airway due to the altered mental status and signiﬁcant
secretions, and involves reversal of GABA receptor dysfunc-
tion  with benzodiazepines. Atropine is ineffective, and may
have  the undesired side effect of reducing seizure thresh-
old  in these patients. Initial presentation of poisoning
with permethrins may  mimic  that seen with exposure to
organophosphates and carbamates; however, rapid anal-
ysis  of the offending agent may  assist with the accurate
diagnosis. Thus, a high index of suspicion in patients
presenting with cholinergic signs and neurotoxicity unre-
sponsive  to standard management for organophosphate
poisons should suggest the possibility of permethrin tox-
icity.  Further investigation of this form of poisoning is
recommended.
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